DePuy (LCS Duofix Femoral Component) class action

On 29 August 2012, a provisional settlement of the DePuy knee implants class action was reached. On 3 December 2012, the settlement was approved by the Federal Court of Australia.

The class action was commenced in March 2010 by Pamela Casey on behalf of all patients (known in the class action as 'Group Members') who were surgically implanted with a DePuy LCS Duofix Femoral Component in Australia.

On 3 September 2012, the Federal Court directed that a Settlement Notice be provided to Group Members.

As a result of the Federal Court's approval of the settlement, Group Members can now make individual claims for compensation under the settlement of the class action. 

What are LCS® Duofix™ Femoral Components?

The DePuy LCS Duofix Femoral Component is a knee implant that was manufactured by a UK based company, DePuy International Limited, and distributed within Australia by Johnson & Johnson Medical Pty Limited. In July 2009, DePuy and Johnson & Johnson conducted a voluntary recall of the LCS Duofix Femoral Component in consultation with the Therapeutic Goods Administration.

Details of the relevant product codes for the DePuy LCS Duofix Femoral Component are listed at the bottom of this page.

Settlement of the class action

Details of the settlement are contained in the Settlement Notice, which contains important information regarding the settlement and what Group Members need to do to make a compensation claim under the settlement.

As a result of the orders made by the Federal Court on 3 December 2012, a Liability Protocol and a Compensation Protocol will be used to assess individual claims for compensation by Group Members.

Further information

If you do not understand the Settlement Notice or how it affects your rights, you should seek legal advice.